Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC Gray, Jhanelle E.; Schenker, Michael; Sendur, Mehmet Ali Nahit; Leonova, Viktoriya; Kowalski, Dariusz; Kato, Terufumi; Orlova, Rashida; Yang, James Chih-Hsin; Langleben, Adrian; Pilz, Arnold; Ungureanu, Andrei; Mak, Milena Perez; De Angelis, Flavia; Aggarwal, Himani; Zimmer, Zachary; Zhao, Bin; Shamoun, Mark; Kim, Tae Min Share Save
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib Umemura, Shigeki; Udagawa, Hibiki; Ikeda, Takaya; Murakami, Haruyasu; Daga, Haruko; Toyozawa, Ryo; Kozuki, Toshiyuki; Sakakibara-Konishi, Jun; Ohe, Yuichiro; Morise, Masahiro; Kato, Terufumi; Shingyoji, Masato; Hara, Satoshi; Furuya, Naoki; Takata, Saori; Miyamoto, Shingo; Nakachi, Ichiro; Wakabayashi, Masashi; Nomura, Shogo; Sato, Akihiro; Ishii, Genichiro; Tsuchihara, Katsuya; Sugiyama, Eri; Kirita, Keisuke; Sakai, Tetsuya; Shibata, Yuji; Izumi, Hiroki; Nosaki, Kaname; Zenke, Yoshitaka; Matsumoto, Shingo; Yoh, Kiyotaka; Niho, Seiji; Goto, Koichi Share Save
HORIZON-01: a phase I-III platform study evaluating the efficacy and safety of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) Popat, Sanjay; Januszewski, Adam; Cove-Smith, Laura; Baijal, Shobhit; Imseeh, Georgios; Gay, Carl; Kerr, Keith; Kato, Terufumi; Paz-Ares, Luis; Zhou Caicun; Redhead, Karl; Theogaraj, Elizabeth; Shagan, Sarah M.; Solomon, Benjamin J. Share Save
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy Hochmair, Maximilian; Schenker, Michael; Dols, Manuel Cobo; Kim, Tae Min; Ozyilkan, Ozgur; Smagina, Maria; Leonova, Viktoriya; Kato, Terufumi; Fedenko, Alexander; De Angelis, Flavia; Rittmeyer, Achim; Gray, Jhanelle E.; Greystoke, Alastair; Aggarwal, Himani; Huang, Qinlei; Zhao, Bin; Lara-Guerra, Humberto; Nadal, Ernest Share Save
Share Save
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study Garassino, Marina Chiara; He, Yong; Ahn, Myung-Ju; V. Orlov, Sergey; Potter, Vanessa; Kato, Terufumi; Laskin, Janessa; Voon, Pei Jye; Reungwetwattana, Thanyanan; Ramalingam, Suresh S.; Wu, Yi-Long; Albayaty, Muna; Cross, Sarah L.; Huang, Xiangning; Kulkarni, Dakshayini Share Save
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study Lu, S.; Ahn, M. -j.; Reungwetwattana, T.; Oezgueroglu, M.; Kato, T.; Yang, J. c. -h.; Huang, M.; Fujiki, F.; Inoue, T.; Quang, L. -v.; Sriuranpong, V.; Vicente, D.; Fuentes, C.; Chaudhry, A. A.; Poole, L.; Monterroso, E. Armenteros; Rukazenkov, Y.; van der Gronde, T.; Ramalingam, S. S. Share Save
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE) Nakayama, Sayuka; Yoshizawa, Ayuha; Tsurutani, Junji; Yoshimura, Kenichi; Aoki, Gaku; Iwamoto, Takayuki; Nagase, Hiroyuki; Sugimoto, Naoya; Kobayashi, Konomi; Izumi, Shinyu; Kato, Terufumi; Miyazaki, Yasunari; Kurihara, Yasuyuki; Taira, Naruto; Aihara, Tomohiko; Kikawa, Yuichiro; Mukai, Hirofumi Share Save
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study Kenmotsu, Hirotsugu; Sakai, Kazuko; Mori, Keita; Kato, Terufumi; Sugawara, Shunichi; Kirita, Keisuke; Yoneshima, Yasuto; Azuma, Koichi; Nishino, Kazumi; Teraoka, Shunsuke; Koyama, Ryo; Masuda, Ken; Hayashi, Hidetoshi; Toyozawa, Ryo; Miura, Satoru; Sato, Yuki; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Nishio, Kazuto; Takahashi, Toshiaki Share Save
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC Hochmair, Maximilian J.; Vermaelen, Karim; Mountzios, Giannis; Carcereny, Enric; Dooms, Christophe; Lee, Se-Hoon; Morocz, Eva; Kato, Terufumi; Ciuleanu, Tudor-Eliade; Dy, Grace K.; Parente, Barbara; O'Byrne, Kenneth J.; Chu, Quincy S.; De Castro Junior, Gilberto; Girard, Nicolas; Snyder, Wendy; Tran, Qui; Kormany, William; Houk, Brett; Mehta, Bhakti; Curioni-Fontecedro, Alessandra Share Save
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial Spicer, Jonathan D.; Garassino, Marina C.; Wakelee, Heather; Liberman, Moishe; Kato, Terufumi; Tsuboi, Masahiro; Lee, Se-Hoon; Chen, Ke-Neng; Dooms, Christophe; Majem, Margarita; Eigendorff, Ekkehard; Martinengo, Gaston L.; Bylicki, Olivier; Rodriguez-Abreu, Delvys; Chaft, Jamie E.; Novello, Silvia; Yang, Jing; Arunachalam, Ashwini; Keller, Steven M.; Samkari, Ayman; Gao, Shugeng Share Save
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC Lu, Shun; Kato, Terufumi; Dong, Xiaorong; Ahn, Myung-Ju; Quang, Le-Van; Soparattanapaisarn, Nopadol; Inoue, Takako; Wang, Chih-Liang; Huang, Meijuan; Yang, James Chih-Hsin; Cobo, Manuel; Ozguroglu, Mustafa; Casarini, Ignacio; Khiem, Dang-Van; Sriuranpong, Virote; Cronemberger, Eduardo; Takahashi, Toshiaki; Runglodvatana, Yotsawaj; Chen, Ming; Huang, Xiangning; Grainger, Ellie; Ghiorghiu, Dana; van der Gronde, Toon; Ramalingam, Suresh S. Share Save
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors Horaguchi, Shun; Nakahara, Yoshiro; Igarashi, Yuka; Kouro, Taku; Wei, Feifei; Murotani, Kenta; Udagawa, Seiichi; Higashijima, Naoko; Matsuo, Norikazu; Murakami, Shuji; Kato, Terufumi; Kondo, Tetsuro; Xiang, Huihui; Kasajima, Rika; Himuro, Hidetomo; Tsuji, Kayoko; Mano, Yasunobu; Komahashi, Mitsuru; Miyagi, Yohei; Saito, Haruhiro; Azuma, Koichi; Uehara, Shuichiro; Sasada, Tetsuro Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
